• 1
    Manoussakis MN, Moutsopoulos HM. Sjögren's syndrome: current concepts. In: FauciA, editor. Advances in internal medicine. Vol. 47. St. Louis: Mosby; 2001. p. 191217.
  • 2
    Moutsopoulos HM, Manoussakis MN. Lumping or splitting autoimmune rheumatic disorders? Lessons from Sjögren's syndrome. Br J Rheumatol 1998; 37: 12634.
  • 3
    Moutsopoulos HM, Webber BL, Vlagopoulos TP, Decker JL. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med 1979; 66: 7336.
  • 4
    Manthorpe R, Morling N, Platz P, Ryder LP, Svejgaard A, Thomsen M. HLA-D antigen frequencies in Sjögren's syndrome: differences between the primary and secondary form. Scand J Rheumatol 1981; 10: 1248.
  • 5
    Heaton JM. Sjögren's syndrome and systemic lupus erythematosus. Br Med J 1959; 1: 4669.
  • 6
    Grennan DM, Ferguson M, Williamson J, Mavrikakis M, Dick WC, Buchanan WW. Sjögren's syndrome in systemic lupus erythematosus. Part 1. The frequency of the clinical and subclinical features of Sjögren's syndrome in patients with systemic lupus erythematosus. NZ Med J 1977; 86: 3746.
  • 7
    Andonopoulos AP, Skopouli FN, Dimou GS, Drosos AA, Moutsopoulos HM. Sjögren's syndrome in systemic lupus erythematosus. J Rheumatol 1990; 17: 2014.
  • 8
    Nossent JC, Swaak AJ. Systemic lupus erythematosus. VII. Frequency and impact of secondary Sjögren's syndrome. Lupus 1998; 7: 2314.
  • 9
    McDonagh JE, Isenberg DA. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 2000; 59: 2302.
  • 10
    Provost TT, Watson R, Simmons-O'Brien E. Anti-Ro (SS-A) antibody positive Sjögren's/lupus erythematosus overlap syndrome. Lupus 1997; 6: 10511.
  • 11
    Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS. J Rheumatol 1998; 25: 638.
  • 12
    Moutsopoulos HM, Klippel JH, Pavlidis N, Wolf RO, Sweet JB, Steinberg AD, et al. Correlative histologic and serologic findings of sicca syndrome in patients with systemic lupus erythematosus. Arthritis Rheum 1980; 23: 3640.
  • 13
    Vitali C, Bombardieri S, Moutsopoulos HM, and The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 1996; 55: 11621.
  • 14
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and Th European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 5548.
  • 15
    Smith EL, Shmerling RH. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses and opportunities for improvement. Lupus 1999; 8: 58695.
  • 16
    Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968; 21: 65660.
  • 17
    Gladman DD, Urowitz MB, Cole E, Ritchie S, Chang CH, Churg J. Kidney biopsy in systemic lupus erythematosus: a clinical-morphologic evaluation. Q J Med 1989; 73: 112533.
  • 18
    ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599608.
  • 19
    Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 130911.
  • 20
    Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 55765.
  • 21
    Jobson JD. Applied multivariate data analysis. New York: Springer; 1992.
  • 22
    Vlachoyiannopoulos PG, Karassa FB, Karakostas KX, Drosos AD, Moutsopoulos HM. Systemic lupus erythematosus in Greece: clinical features, evolution and outcome: a descriptive analysis of 292 patients. Lupus 1993; 2: 30312.
  • 23
    Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000; 29: 296304.
  • 24
    Steinberg AD, Talal N. The coexistence of Sjögren's syndrome and systemic lupus erythematosus. Ann Intern Med 1971; 74: 5561.
  • 25
    Alarcon-Segovia D, Ibanez G, Velazquez-Forero F, Hernandez-Ortiz J, Gonzalez-Jimenez Y. Sjögren's syndrome in systemic lupus erythematosus: clinical and subclinical manifestations. Ann Intern Med 1974; 81: 57783.
  • 26
    Gilboe IM, Kvien TK, Uhlig T, Husby G. Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis 2001; 60: 11039.
  • 27
    Skopouli FN, Siouna-Fatourou H, Dimou GS, Galanopoulou D, Papadimitriou CS, Moutsopoulos HM. Histologic lesion in labial salivary glands of patients with systemic lupus erythematosus. Oral Surg Oral Med Oral Pathol 1991; 72: 20812.
  • 28
    Lie JT. Vasculopathy of the antiphospholipid syndrome revisited: thrombosis is the culprit and vasculitis the consort. Lupus 1996; 5: 36871.
  • 29
    Alexander EL, McNicholl J, Watson RM, Bias W, Reichlin M, Provost TT. The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome. J Invest Dermatol 1989; 93: 7516.
  • 30
    Galeazzi M, Sebastiani GD, Morozzi G, Carcassi C, Ferrara GB, Scorza R, et al, and The European Concerted Action on the Immunogenetics of SLE. HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus. Medicine (Baltimore) 2002; 81: 16978.
  • 31
    Ricchiuti V, Isenberg D, Muller S. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome. J Autoimmun 1994; 7: 61121.
  • 32
    Tsuzaka K, Fujii T, Akizuki M, Mimori T, Tojo T, Fujii H, et al. Clinical significance of antibodies to native or denatured 60-kd or 52-kd Ro/SS-A proteins in Sjögren's syndrome. Arthritis Rheum 1994; 37: 8892.
  • 33
    Wahren M, Solomin L, Pettersson I, Isenberg D. Autoantibody repertoire to Ro/SSA and La/SSB antigens in patients with primary and secondary Sjögren's syndrome. J Autoimmun 1996; 9: 53744.
  • 34
    Roitberg-Tambur A, Friedmann A, Safirman C, Markitziu A, Ben-Chetrit E, Rubinow A, et al. Molecular analysis of HLA class II genes in primary Sjögren's syndrome: a study of Israeli Jewish and Greek non-Jewish patients. Hum Immunol 1993; 36: 23542.
  • 35
    Tzioufas AG, Wassmuth R, Dafni UG, Guialis A, Haga HJ, Isenberg DA, et al. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome: a European multicentre study. Ann Rheum Dis 2002; 61: 398404.
  • 36
    Zufferey P, Meyer OC, Bourgeois P, Vayssairat M, Kahn M. Primary systemic Sjögren's syndrome (SS) preceding systemic lupus erythematosus: a retrospective study of 4 cases in a cohort of 55 SS patients. Lupus 1995; 4: 237.
  • 37
    Kruize AA, Hene RJ, van der Heide A, Bodeutsch C, de Wilde PC, van Bijsterveld OP, et al. Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum 1996; 39: 297303.